S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end
NYSE:FINS

Angel Oak Financial Strategies Income Term Trust (FINS) Stock Price, News & Analysis

$12.39
+0.06 (+0.49%)
(As of 04/19/2024 ET)
Today's Range
$12.33
$12.39
50-Day Range
$12.17
$12.50
52-Week Range
$11.61
$12.55
Volume
24,775 shs
Average Volume
64,809 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
10.09%
Price Target
N/A
FINS stock logo

About Angel Oak Financial Strategies Income Term Trust Stock (NYSE:FINS)

he Angel Oak Financial Strategies Income Term Trust is a closed-end fund that seeks current income with a secondary objective of total return. The Fund utilizes a banking sector debt-centric strategy, which exhibits low historical correlations to other areas of the market. The investment highlights of the Fund include: Access to a niche market segment. Focus on high quality credit with at least 50% of the Fund’s depository institution debt investments publicly rated investment grade or, if deemed unrated, scored as investment grade by Angel Oak’s in-house proprietary BankSURF credit-quality assessment model. Asset class duration historically uncorrelated to interest rates. Benefits from Angel Oak’s extensive resources and expertise in a

FINS Stock Price History

FINS Stock News Headlines

Angel Oak Financial: Dividend Insights
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Angel Oak Financial Strategies Income Term Trust
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
London Looks to Un-Meme the SPAC Market
See More Headlines
Receive FINS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Angel Oak Financial Strategies Income Term Trust and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 3/28 Dividend
3/13/2024
Dividend Payable
3/28/2024
Ex-Dividend for 4/30 Dividend
4/15/2024
Today
4/20/2024
Dividend Payable
4/30/2024

Industry, Sector and Symbol

Industry
Asset Management
Sub-Industry
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$8.53 million

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

FINS Stock Analysis - Frequently Asked Questions

How have FINS shares performed in 2024?

Angel Oak Financial Strategies Income Term Trust's stock was trading at $11.91 at the beginning of 2024. Since then, FINS stock has increased by 4.0% and is now trading at $12.39.
View the best growth stocks for 2024 here
.

Are investors shorting Angel Oak Financial Strategies Income Term Trust?

Angel Oak Financial Strategies Income Term Trust saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 18,700 shares, an increase of 79.8% from the March 15th total of 10,400 shares. Based on an average daily trading volume, of 70,000 shares, the short-interest ratio is currently 0.3 days.
View Angel Oak Financial Strategies Income Term Trust's Short Interest
.

How often does Angel Oak Financial Strategies Income Term Trust pay dividends? What is the dividend yield for Angel Oak Financial Strategies Income Term Trust?

Angel Oak Financial Strategies Income Term Trust announced a monthly dividend on Monday, April 1st. Shareholders of record on Tuesday, April 16th will be paid a dividend of $0.109 per share on Tuesday, April 30th. This represents a $1.31 dividend on an annualized basis and a dividend yield of 10.56%. The ex-dividend date is Monday, April 15th.
Read our dividend analysis for FINS
.

Is Angel Oak Financial Strategies Income Term Trust a good dividend stock?

Angel Oak Financial Strategies Income Term Trust (NYSE:FINS) pays an annual dividend of $1.25 per share and currently has a dividend yield of 0.07%.
Read our dividend analysis for FINS.

What ETF holds Angel Oak Financial Strategies Income Term Trust's stock?

First Trust Income Opportunities ETF holds 25,254 shares of FINS stock, representing 1.01% of its portfolio.

What other stocks do shareholders of Angel Oak Financial Strategies Income Term Trust own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Angel Oak Financial Strategies Income Term Trust investors own include ONEOK (OKE), BlackRock Enhanced Equity Dividend Trust (BDJ), BP (BP), International Business Machines (IBM), Kayne Anderson Energy Infrastructure Fund (KYN), Altria Group (MO), Pfizer (PFE), AbbVie (ABBV) and Bristol-Myers Squibb (BMY).

Who are Angel Oak Financial Strategies Income Term Trust's major shareholders?

Angel Oak Financial Strategies Income Term Trust's stock is owned by many different retail and institutional investors. Top institutional investors include Ignite Planners LLC (0.00%). Insiders that own company stock include Johannes Palsson and Michael Fierman.
View institutional ownership trends
.

How do I buy shares of Angel Oak Financial Strategies Income Term Trust?

Shares of FINS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:FINS) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners